Houston Methodist Sugar Land Hospital, located in Sugar Land, Texas, is one of seven community hospitals that are part of Houston Methodist. It employs more than 2,200 people, has an estimated 1,100 affiliated doctors and admits more than 17,000 patients annually.

During the past decade, Houston Methodist Sugar Land Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 13 clinical trials were completed, i.e. on average, 40.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 13 clinical trials were completed. i.e. 144.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Houston Methodist Sugar Land Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "The Methodist Hospital Research Institute" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "GOG Foundation" with 3 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Methodist Sugar Land Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Novartis" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Houston Methodist Sugar Land Hospital" are "Ovarian Seromucinous Carcinoma" (6 trials), "Breast Cancer" (5 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (4 trials), "Fallopian Tube Transitional Cell Carcinoma" (4 trials) and "Ovarian Clear Cell Adenocarcinoma" (4 trials). Many other conditions were trialed in "Houston Methodist Sugar Land Hospital" in a lesser frequency.

Most popular intervention types in "Houston Methodist Sugar Land Hospital" are "Drug" (32 trials), "Other" (26 trials), "Biological" (15 trials), "Procedure" (13 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (14 trials), "Laboratory Biomarker Analysis" (12 trials), "Paclitaxel" (12 trials), "Questionnaire Administration" (11 trials) and "Carboplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "Houston Methodist Sugar Land Hospital" are 21 trials for "Female" genders and 20 trials for "All" genders.

Currently, there are NaN active trials in "Houston Methodist Sugar Land Hospital". undefined are not yet recruiting, 11 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Houston Methodist Sugar Land Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Houston Methodist Sugar Land Hospital, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".